SR9 - Trigger concerns prompt Ruger recall
Sturm Ruger & Company, Inc. (NYSE: RGR) has issued a recall notice for their SR9 pistols manufactured between October 2007 and April 2008. The recall notice was issued yesterday, citing concerns that the SR9 can, under certain conditions, fire if dropped with their manual safeties in the ‘off’ or ‘fire’ position and a round in the chamber. The pistols will not fire if the manual safety is in the ‘on’ or ‘safe’ position.”
Ruger says it is finalizing the design of a new trigger group which addresses the problem and prevents firing when dropped. The company also says the new part must be installed at their factory in Prescott, Arizona. There, workers will remove the old part, and perform the retrofit no charge all Ruger SR9 pistols with serial number prefix “330” (330-XXXXX).
The pertinent contact information for SR9 owners to obtain information or register for the recall are:
* Visiting the Ruger website at: www.ruger.com/SR9Recall/
* E-mail: SR9recall@ruger.com
* Fax: 928-541-8873
* Calling the Ruger SR9 Recall Hotline at 800-784-3701 between 8:00 a.m. and 8:00 p.m. EDT.
When the retrofit triggers are ready, Ruger will send consumers a shipping box, label and instructions for returning their SR9 pistol to the Ruger factory in Prescott.
Shipping to and from Ruger will be done at no charge to consumers, and the company promises the retrofit work will be completed “promptly”.
As an incentive for cooperating with the recall, all SR9 owners returning their pistol for the retrofit will receive a free SR9 magazine with their repaired SR9 as a “thank you” for their patience and cooperation.
In the meantime, all owners of SR9 pistols are urged not to use their pistol until such time as it has been retrofitted with the new trigger groups.
If you must use your SR9, Ruger says you should always keep the manual safety in the “on” or “safe” position except when actually firing.
Shares of Sturm, Ruger & Co. rose 8 cents to $7.95 in after-hours trading after falling 45 cents, or 5.4 percent, to close at $7.86 on Wednesday. The stock has traded in a 52-week range of $7.22 to $22.58.